cbdMD, Inc. (YCBD)

cbdMD Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Revenue	19.19	19.48	24.16	35.4	44.48
Revenue Growth (YoY)	-1.50%	-19.35%	-31.77%	-20.41%	6.20%
Cost of Revenue	7.22	7.49	9.18	13.07	14.5
Gross Profit	11.97	12	14.98	22.34	29.99
Selling, General & Admin	11.99	13.27	18.93	33.29	43.37
Research & Development	0.03	0.04	0.17	0.63	1.42
Amortization of Goodwill & Intangibles	0.77	0.7	1.4	0.88	-
Other Operating Expenses	0.98	0.86	3.34	3.89	3.79
Operating Expenses	14.13	15.31	24.25	39.65	49.6
Operating Income	-2.16	-3.32	-9.27	-17.31	-19.62
Interest Expense	-	-0.03	-	-	-0.03
Interest & Investment Income	0.03	-	0.06	0.02	-
Other Non Operating Income (Expenses)	-	-	-	0.24	0.03
EBT Excluding Unusual Items	-2.13	-3.34	-9.2	-17.06	-19.62
Merger & Restructuring Charges	-	-	-	-0.6	-
Impairment of Goodwill	-	-	-	-56.67	-
Gain (Loss) on Sale of Investments	-	-	-0.7	-0.03	0.55
Gain (Loss) on Sale of Assets	-	-	-	0.09	-
Asset Writedown	-	-	-13.22	-4.29	-
Other Unusual Items	0.09	-0.36	0.19	8.47	-5.22
Pretax Income	-2.04	-3.7	-22.94	-70.08	-24.29
Income Tax Expense	-	-	-	-	-0.9
Earnings From Continuing Operations	-2.04	-3.7	-22.94	-70.08	-23.39
Net Income	-2.04	-3.7	-22.94	-70.08	-23.39
Preferred Dividends & Other Adjustments	2.33	4	4	4	2.55
Net Income to Common	-4.38	-7.7	-26.94	-74.09	-25.95
Shares Outstanding (Basic)	4	1	0	0	0
Shares Outstanding (Diluted)	4	1	0	0	0
Shares Change (YoY)	646.22%	113.25%	52.31%	8.76%	21.62%
EPS (Basic)	-1.09	-14.29	-106.57	-446.37	-170.04
EPS (Diluted)	-1.09	-14.29	-106.57	-446.40	-170.04
Free Cash Flow	-1.64	-0.54	-4.6	-15.66	-14.44
Free Cash Flow Per Share	-0.41	-1.01	-18.20	-94.33	-94.59
Gross Margin	62.37%	61.57%	62.01%	63.09%	67.41%
Operating Margin	-11.27%	-17.02%	-38.37%	-48.89%	-44.10%
Profit Margin	-22.80%	-39.55%	-111.53%	-209.26%	-58.34%
Free Cash Flow Margin	-8.53%	-2.79%	-19.04%	-44.22%	-32.45%
EBITDA	-1.04	-2.17	-7.47	-15.48	-18.6
EBITDA Margin	-5.40%	-11.12%	-30.92%	-43.72%	-41.81%
D&A For EBITDA	1.13	1.15	1.8	1.83	1.02
EBIT	-2.16	-3.32	-9.27	-17.31	-19.62
EBIT Margin	-11.27%	-17.02%	-38.37%	-48.89%	-44.10%
Revenue as Reported	19.19	19.48	24.16	35.4	44.48

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q